Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

NCT07282158 · Fred Hutchinson Cancer Center

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title

Adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout (HOPE-C)

About this study

OUTLINE: OBJECTIVE 1 DEVELOPMENT OF INTERVENTION: Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study. OBJECTIVE 2 PILOT TRIAL: Clinicians attend HOPE-C sessions (changing their narrative, managing life's uncertainty and finding meaning) once weekly for 4 weeks, with each session lasting approximately 30-45 minutes. Clinicians complete a questionnaire before and after completing all HOPE-C sessions. OBJECTIVE 3: Clinicians may undergo an interview after completing HOPE-C sessions.

Eligibility criteria

Inclusion Criteria: * Age 18 years of age or older * English speaking * Able to provide informed consent * Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])

Study design

Enrollment target: 25 participants

Allocation: na

Masking: none

Age groups: adult, older_adult

Timeline

Starts: 2026-05-01

Estimated completion: 2029-12-31

Last updated: 2026-04-08

Interventions

Behavioral: Behavioral InterventionOther: InterviewOther: Survey Administration

Primary outcomes

• Objective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C) (Day 1)
• Objective 2: Feasibility (Accrual rate) (At time of enrollment)
• Objective 2: Feasibility (Rate of intervention completion) (At 4 weeks)

Sponsor

Fred Hutchinson Cancer Center · other

With: Andy Hill CARE Fund

Contacts & investigators

ContactMegan J. Shen, PhD · contact · mshen2@fredhutch.org · 206-667-4172

InvestigatorMegan J. Shen, PhD · principal_investigator, Fred Hutch/University of Washington Cancer Consortium

All locations (1)

Fred Hutch/University of Washington Cancer ConsortiumRecruiting

Seattle, Washington, United States

View on ClinicalTrials.gov ↗Find similar trials